We provide investors with an assessment of a potential investment’s culture of compliance, adherence to government rules and billing accuracy and benchmark the company with its peers.
Our proprietary process has been honed through a decade of diligence work to ensure our clients receive an accurate, timely assessment of a company’s clinical processes and coding accuracy as well as the risk of financial recoupment in the event of an audit.
We work with healthcare operators to identify areas for improvement in their compliance process and assist them in developing a plan to achieve best practices.
Our senior clinical team helps company management develop and implement compliance plans, quality plans, employee policies and procedures, and HIPAA processes and install a process for ongoing monitoring. In addition, our team works with the management of companies under a Corporate Integrity Agreement to ensure compliance with their obligations.
In addition to clinical quality and compliance diligence assessments, we provide investors with outlook for a potential investment’s overall Revenue Cycle Management functionality through assessment of key processes and capabilities.
Our proprietary process has been honed through a decade of diligence work and extensive experience with RCM operational dynamics across the spectrum of provider types, laboratories, and healthcare corporations providing reimbursed services.
We put a senior compliance leader at the center of your organization, one who runs the program rather than just reports on it. Our executives step into the Chief Compliance Officer seat as your fractional officer, owning risk, auditing, policy, and board reporting day to day. When a team already has an officer in place, we work alongside them, adding senior capacity and an experienced second set of eyes. Across the full spectrum of healthcare organizations, we have built programs that hold up in diligence, in the boardroom, and under regulatory review.
A private equity firm sought to evaluate the compliance policies and practices of two potential investments in podiatry physician practices that serve the commercial and government pay populations.
Marwood found that the target company’s compliance program, clinical charts and HIPAA policies were in need of improvement; thus, the Company is at moderate to high risk of repayment or recoupment in the event of payor scrutiny. There were numerous errors in the company’s E&M coding and DME documentation. Marwood provided specific recommendations to the Client.